Renal denervation: potential indications and review of trial data

Abstract

Renal sympathetic denervation is a novel, endovascular treatment with potential utility in resistant hypertension. First pioneered in humans in 2010, conflicting data exist regarding the efficacy of this treatment. This article will review the evidence to date, the scientific rationale for sympathetic denervation as a treatment for hypertension and consider other possible conditions where the therapy may be of benefit.

Keywords: Renal denervation; hypertension; renal sympathetic denervation; symplicity.